Showing results (2701-2710 of 2,835) with videos related to

Sort By:
Pageof 284
Targeted Oncology|December 9, 2017
Early Metabolic Change after Induction Chemotherapy Predicts Histologic Response and Prognosis in Patients with Esophageal Cancer: Secondary Analysis of a Randomized TrialKazuto Harada, Xuemei Wang, Yusuke Shimodaira, et al.
Journal of the National Cancer Institute|April 13, 2011
Genome-wide association study of survival in non-small cell lung cancer patients receiving platinum-based chemotherapyXifeng Wu, Yuanqing Ye, Rafael Rosell, et al.
The Annals of Thoracic Surgery|December 9, 2021
Salvage Esophagectomy Definition Influences Comparative Outcomes in Esophageal Squamous Cell CancersNicolas Zhou, Wayne L Hofstetter, , et al.
Frontiers in Oncology|August 28, 2023
Radiographic response to neoadjuvant therapy in pleural mesothelioma should serve as a guide for patient selection for cytoreductive operationsNathaniel Deboever, Nicolas Zhou, Daniel J McGrail, et al.
Neuroepidemiology|October 28, 2015
Stroke Prevalence, Mortality and Disability-Adjusted Life Years in Children and Youth Aged 0-19 Years: Data from the Global and Regional Burden of Stroke 2013Rita V Krishnamurthi, Gabrielle deVeber, Valery L Feigin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 20, 2018
Landscape of EGFR-Dependent and -Independent Resistance Mechanisms to Osimertinib and Continuation Therapy Beyond Progression in EGFR-Mutant NSCLCXiuning Le, Sonam Puri, Marcelo V Negrao, et al.
British Journal of Cancer|December 14, 2017
Influence of induction chemotherapy in trimodality therapy-eligible oesophageal cancer patients: secondary analysis of a randomised trialYusuke Shimodaira, Rebecca S Slack, Kazuto Harada, et al.
Nature Communications|April 25, 2024
Group 3 medulloblastoma transcriptional networks collapse under domain specific EP300/CBP inhibitionNoha A M Shendy, Melissa Bikowitz, Logan H Sigua, et al.
Lung Cancer (Amsterdam, Netherlands)|January 17, 2022
Surgical approach does not influence changes in circulating immune cell populations following lung cancer resectionNathaniel Deboever, Daniel J McGrail, Younghee Lee, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 22, 2022
Surgical outcomes after neoadjuvant nivolumab or nivolumab with ipilimumab in patients with non-small cell lung cancerBoris Sepesi, Nicolas Zhou, William N William, et al.
Pageof 284